BOSTON SCIENTIFIC CORPORATION Long-Term Debt, Maturity, after Year Five
BOSTON SCIENTIFIC CORPORATION (BSX) had Long-Term Debt, Maturity, after Year Five of $2.35 billion as of 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2017-05-03
- 2017-03-31: Long-Term Debt, Maturity, after Year Five $2.35B.
- 2016-12-31: Long-Term Debt, Maturity, after Year Five $2.35B.
- 2016-09-30: Long-Term Debt, Maturity, after Year Five $2.35B.
- 2016-06-30: Long-Term Debt, Maturity, after Year Five $2.35B.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2017-03-31 | $2.35B 10-Q · filed 2017-05-03 |
| 2016-12-31 | $2.35B 10-K · filed 2017-02-23 |
| 2016-09-30 | $2.35B 10-Q · filed 2016-11-03 |
| 2016-06-30 | $2.35B 10-Q · filed 2016-08-03 |
| 2016-03-31 | $2.35B 10-Q · filed 2016-05-04 |
| 2015-12-31 | $2.35B 10-K · filed 2016-02-24 |
| 2015-09-30 | $4.17B 10-Q · filed 2015-11-04 |
| 2015-06-30 | $3.80B 10-Q · filed 2015-08-06 |
| 2015-03-31 | $1.95B 10-Q · filed 2015-05-06 |
| 2014-12-31 | $1.95B 10-K · filed 2015-02-25 |
| 2014-09-30 | $1.95B 10-Q · filed 2014-11-05 |
| 2014-06-30 | $1.95B 10-Q · filed 2014-08-06 |
| 2014-03-31 | $1.95B 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.95B 10-K · filed 2014-02-26 |
| 2013-09-30 | $2.79B 10-Q · filed 2013-11-05 |
| 2013-06-30 | $1.50B 10-Q · filed 2013-08-07 |
| 2013-03-31 | $1.50B 10-Q · filed 2013-05-07 |
| 2012-12-31 | $1.50B 8-K · filed 2013-05-29 |
| 2012-09-30 | $1.75B 10-Q · filed 2012-11-06 |
| 2012-06-30 | $1.75B 10-Q · filed 2012-08-07 |
| 2012-03-31 | $1.75B 10-Q · filed 2012-05-03 |
| 2011-12-31 | $1.75B 10-K · filed 2012-02-17 |
| 2011-09-30 | $2.35B 10-Q · filed 2011-11-08 |
| 2011-06-30 | $2.35B 10-Q · filed 2011-08-05 |
| 2011-03-31 | $2.35B 10-Q · filed 2011-05-05 |
| 2010-12-31 | $2.35B 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |